FOXO Technologies Inc. (FOXO) stock
FOXOOTCServices-Commercial Physical & Biological ResearchFiscal year ends December 31Also trades as FOXOW
$0.10−0.01 (-9.09%)
Close on Oct 19, 2026Market cap –P/E –Yield –
FOXO Technologies r&d expenses
Research and development expenses are spending on new products and technology.
FOXO Technologies's R&D Expenses for the twelve months ending Jun 30, 2026 was $171.57K, up 50.5% year over year. For fiscal 2025 it was $182.50K, down 41.6% from the year before. The highest annual figure on record is $4.88M in fiscal 2021.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $182.50K | -41.6% |
| FY2024 | Dec 31, 2024 | $312.27K | -65.3% |
| FY2023 | Dec 31, 2023 | $900.43K | -70.4% |
| FY2022 | Dec 31, 2022 | $3.05M | -37.5% |
| FY2021 | Dec 31, 2021 | $4.88M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $23.70K | -41.0% |
| Q1 FY2026 | Mar 31, 2026 | $35.55K | +18.5% |
| Q4 FY2025 | Dec 31, 2025 | $35.22K | – |
| Q3 FY2025 | Sep 30, 2025 | $77.10K | +76.0% |
| Q2 FY2025 | Jun 30, 2025 | $40.18K | -61.0% |
| Q1 FY2025 | Mar 31, 2025 | $30.00K | -81.9% |
| Q4 FY2024 | Dec 31, 2024 | $0 | -100.0% |
| Q3 FY2024 | Sep 30, 2024 | $43.81K | -86.8% |
| Q2 FY2024 | Jun 30, 2024 | $103.10K | -66.6% |
| Q1 FY2024 | Mar 31, 2024 | $165.36K | -81.4% |
| Q3 FY2023 | Sep 30, 2023 | $283.00K | -49.3% |
| Q2 FY2023 | Jun 30, 2023 | $333.00K | -66.7% |
| Q1 FY2023 | Mar 31, 2023 | $309.00K | -48.6% |
| Q4 FY2022 | Dec 31, 2022 | $887.00K | +59.0% |
| Q3 FY2022 | Sep 30, 2022 | $558.00K | -66.5% |
| Q2 FY2022 | Jun 30, 2022 | $1.00M | – |
| Q1 FY2022 | Mar 31, 2022 | $601.00K | – |
| Q4 FY2021 | Dec 31, 2021 | $558.00K | – |
| Q3 FY2021 | Sep 30, 2021 | $1.67M | – |
See a number that looks wrong?